Wellgistics director granted 5M shares, 5M warrants
Wellgistics Health, Inc. director Surendra K. Ajjarapu received a large equity compensation package.
Rhea-AI Filing Summary
Wellgistics Health, Inc. director Surendra K. Ajjarapu received a large equity compensation package. On March 31, he was granted 5,000,000 shares of common stock at $0.20 per share as compensation for his service, bringing his direct holdings to 7,882,247 shares.
He was also granted 5,000,000 warrants to purchase common stock with a $0.0001 exercise price, exercisable from March 31 and expiring on March 31, 2031. Both the shares and warrants were issued as compensation in transactions exempt from registration under Section 4(a)(2) of the Securities Act of 1933.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 10,000,000 shares
Grant/Award
2 txns
Insider
AJJARAPU SURENDRA K
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Warrant | 5,000,000 | $0.0001 | $500.00 |
| Grant/Award | Common Stock | 5,000,000 | $0.20 | $1.00M |
Holdings After Transaction:
Warrant — 5,000,000 contracts (Direct);
Common Stock — 7,882,247 shares (Direct)
Footnotes (2)
- F1. The Issuer issued the Reporting Person 5,000,000 shares of common stock (the "Shares") as compensation for the Reporting Person's service to the Issuer. The Shares were issued in a transaction exempt from registration under Section 4(a)(2) of the Securities Act of 1933.
- F2. The Issuer issued the Reporting Person 5,000,000 warrants to purchase common stock (the "Warrants") as compensation for the Reporting Person's service to the Issuer. The Warrants were issued in a transaction exempt from registration under Section 4(a)(2) of the Securities Act of 1933.
Key Figures
Common stock grant: 5,000,000 shares at $0.20
Shares held after grant: 7,882,247 shares
Warrant grant size: 5,000,000 warrants
+3 more
6 metrics
Common stock grant
5,000,000 shares at $0.20
Compensation grant on March 31, 2026
Shares held after grant
7,882,247 shares
Director’s direct holdings after March 31, 2026 grant
Warrant grant size
5,000,000 warrants
Compensation grant on March 31, 2026
Warrant exercise price
$0.0001 per share
Exercise price for 5,000,000 warrants
Warrant underlying shares
5,000,000 common shares
Underlying common stock for granted warrants
Warrant expiration
March 31, 2031
Expiration date of director’s warrant grant
Key Terms
warrants, transaction exempt from registration, Section 4(a)(2) of the Securities Act of 1933, grant, award, or other acquisition
4 terms
warrants financial
"The Issuer issued the Reporting Person 5,000,000 warrants to purchase common stock"
Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.
transaction exempt from registration regulatory
"The Shares were issued in a transaction exempt from registration under Section 4(a)(2)"
Section 4(a)(2) of the Securities Act of 1933 regulatory
"exempt from registration under Section 4(a)(2) of the Securities Act of 1933"
grant, award, or other acquisition financial
"transaction code description: Grant, award, or other acquisition"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did WGRX director Surendra Ajjarapu report on this Form 4/A?
Director Surendra K. Ajjarapu reported receiving 5,000,000 shares of Wellgistics Health common stock and 5,000,000 warrants as compensation. Both awards were granted on March 31 and reflect non-market, compensation-related acquisitions rather than open-market purchases or sales.
What are the key terms of the 5,000,000 WGRX warrants granted to the director?
The 5,000,000 warrants allow Surendra K. Ajjarapu to purchase Wellgistics Health common stock at an exercise price of $0.0001 per share. They became exercisable on March 31 and are scheduled to expire on March 31, 2031, providing a long-dated equity incentive.
Was the WGRX director’s stock and warrant compensation registered with the SEC?
The 5,000,000 shares and 5,000,000 warrants issued to Surendra K. Ajjarapu were not registered offerings. They were issued as compensation in transactions exempt from registration under Section 4(a)(2) of the Securities Act of 1933, according to the filing footnotes.
Did the WGRX Form 4/A disclose any insider stock sales or open-market purchases?
The Form 4/A shows no open-market stock purchases or sales by Surendra K. Ajjarapu. It reports only compensation-related acquisitions: 5,000,000 shares of common stock and 5,000,000 warrants, both recorded under transaction code A for grants or awards.
AI-generated analysis. How Rhea-AI works. Not financial advice.
